Predictive In Silico Studies of Human 5-hydroxytryptamine Receptor Subtype 2B (5-HT2B) and Valvular Heart Disease

E-ISSN： 1873-4294|13|11|1353-1362

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.11, 2013-06, pp. : 1353-1362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT 1B/1D/2 receptor antagonist properties

By Pullar I.A. Boot J.R. Carney S.L. Cohen M.L. Colvin E.M. Conway R.G. Hardy C.H.L. Lucaites V.L. Nelson D.L. Schenck K.W. Tomlinson R. Wedley S.

European Journal of Pharmacology, Vol. 432, Iss. 1, 2001-11 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite

In silico Modeling Studies of 5-HT2B Antagonistic Activity of 2-(2- phenylethyl)chromone Derivatives from Cucumis melo Seeds

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-08 ,pp. : 840-844

Bentham Science Publishers

Access to resources Recommend Favorite

Studies on the role of 5-HT 2C and 5-HT 2B receptors in regulating generalised seizure threshold in rodents

By Upton N. Stean T. Middlemiss D. Blackburn T. Kennett G.

European Journal of Pharmacology, Vol. 359, Iss. 1, 1998-10 ,pp. : 33-40

Elsevier

Access to resources Recommend Favorite

Human 5-HT 5 receptors: the 5-HT 5A receptor is functional but the 5-HT 5B receptor was lost during mammalian evolution

By Grailhe R. Grabtree G.W. Hen R.

European Journal of Pharmacology, Vol. 418, Iss. 3, 2001-04 ,pp. : 157-167

Elsevier

Access to resources Recommend Favorite

5-Hydroxytryptamine (5-HT) Receptor Ligands

Current Pharmaceutical Design, Vol. 13, Iss. 25, 2007-09 ,pp. : 2621-2637

Bentham Science Publishers

Access to resources Recommend Favorite